Fjarde Ap-fonden’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,930
| Closed | -$1.47M | – | 519 |
|
|
2025
Q1 | $1.47M | Sell |
51,930
-7,800
| -13% | -$221K | 0.02% | 483 |
|
|
2024
Q4 | $2.48M | Buy |
59,730
+3,300
| +6% | +$137K | 0.03% | 454 |
|
|
2024
Q3 | $3.77M | Buy |
+56,430
| New | +$3.77M | 0.04% | 404 |
|
|
2024
Q1 | $5.37M | Buy |
50,430
+2,400
| +5% | +$256K | 0.06% | 329 |
|
|
2023
Q4 | $4.78M | Sell |
48,030
-3,000
| -6% | -$298K | 0.06% | 338 |
|
|
2023
Q3 | $5.27M | Sell |
51,030
-900
| -2% | -$93K | 0.07% | 293 |
|
|
2023
Q2 | $6.31M | Buy |
51,930
+3,800
| +8% | +$462K | 0.08% | 265 |
|
|
2023
Q1 | $7.39M | Sell |
48,130
-2,800
| -5% | -$430K | 0.1% | 222 |
|
|
2022
Q4 | $9.15M | Sell |
50,930
-9,800
| -16% | -$1.76M | 0.13% | 185 |
|
|
2022
Q3 | $8.68M | Hold |
60,730
| – | – | 0.11% | 194 |
|
|
2022
Q2 | $8.68M | Sell |
60,730
-24,100
| -28% | -$3.44M | 0.11% | 194 |
|
|
2022
Q1 | $14.6M | Sell |
84,830
-3,300
| -4% | -$568K | 0.14% | 145 |
|
|
2021
Q4 | $22.4M | Sell |
88,130
-4,930
| -5% | -$1.25M | 0.2% | 100 |
|
|
2021
Q3 | $35.8M | Sell |
93,060
-11,170
| -11% | -$4.3M | 0.33% | 62 |
|
|
2021
Q2 | $24.5M | Buy |
104,230
+9,300
| +10% | +$2.19M | 0.22% | 94 |
|
|
2021
Q1 | $12.4M | Buy |
94,930
+900
| +1% | +$118K | 0.11% | 171 |
|
|
2020
Q4 | $9.82M | Sell |
94,030
-3,100
| -3% | -$324K | 0.09% | 214 |
|
|
2020
Q3 | $6.87M | Buy |
97,130
+1,300
| +1% | +$92K | 0.07% | 252 |
|
|
2020
Q2 | $6.15M | Buy |
+95,830
| New | +$6.15M | 0.08% | 261 |
|